Skip to content

Long-term Cancer Risk in the Randomised Oslo Diet and Antismoking Study

The Effect of Lifestyle Intervention on the Risk of Cancer - A Study of Participants in the Oslo Diet and Antismoking Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03410641
Enrollment
1216
Registered
2018-01-25
Start date
1972-01-15
Completion date
2017-09-30
Last updated
2018-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Gastrointestinal Cancer, Lung Cancer, Prostate Cancer, Urinary Tract Cancer

Keywords

cancer risk, randomised trial, intervention, smoking cessation, dietary intervention, weight loss

Brief summary

This study examines the effect of a five-year multifactorial lifestyle intervention in the Oslo diet and antismoking study on long-term cancer risk. In 1972-1973, 1232 men with high cardiovascular risk profile were randomised to intervention including cholesterol lowering diet, weight loss and antismoking advice, or control (1:1). This study examines the effect of the intervention on 43-year cancer incidence and mortality.

Detailed description

The Oslo diet and antismoking study showed that a 5-year lifestyle intervention reduced the long-term risk of coronary events and mortality. The lifestyle risk factors for cancer are partly similar to those for coronary heart disease, e.g. smoking, high body weight, unfavourable diet. The investigators therefore expect that the intervention has an effect on cancer risk in the long term. In this follow-up study, the investigators analyse the association between the intervention, and cancer incidence and mortality drawn from the Cancer Registry of Norway and the Norwegian Cause of Death Registry from the time of randomisation in 1972/3 until the end of 2015.

Interventions

BEHAVIORALDiet and antismoking advice

Dietary advice with the aim of reducing participant's serum cholesterol levels, including reduction in the intake of saturated fat and cholesterol, and increased intake of polyunsaturated fat, fish, vegetables and fruit. Weight reduction was recommended for overweight men, as well as reduced consumption of sugar rich foods and drinks, and alcoholic beverages. Smokers were advised to stop smoking. The advice was given both individually and in group sessions during a five-year time period from 1972/3 until 1977/8.

Sponsors

Oslo University Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
40 Years to 49 Years
Healthy volunteers
Yes

Inclusion criteria

* participated in screening of coronary risk factors, into which all men born in 1923-1932 and living in Oslo were invited in 1972-1973 * being in the upper quartile of a coronary risk score based on blood pressure, serum total cholesterol concentration and cigarette smoking

Exclusion criteria

* serum total cholesterol level above 9.0 mmol per Liter * having a healthy diet, based on a short dietary history * self-reported cardiovascular disease or diabetes * previous history of cancer

Design outcomes

Primary

MeasureTime frameDescription
Incidence of the group of cancers related to smoking, diet or body mass index43 yearsDiagnosis of carcinoma in the oral cavity, oropharynx, esophagus, stomach, colorectum, liver and intrahepatic bile ducts, pancreas, larynx, trachea, bronchus and lung, urinary tract and thyroid gland, drawn from the Cancer Registry of Norway

Secondary

MeasureTime frameDescription
Cancer incidence43 yearsAny cancer diagnosis, drawn from the Cancer Registry of Norway
Cancer mortality43 yearsMortality in any cancer, drawn from the Norwegian Cause of Death Registry
Incidence of gastrointestinal cancer43 yearsDiagnosis of carcinoma in gastro-intestinal tract, drawn from the Cancer Registry of Norway
Mortality in the group of cancers related to smoking, diet or body mass index43 yearsMortality in cancers in the oral cavity, oropharynx, esophagus, stomach, colorectum, liver and intrahepatic bile ducts, pancreas, larynx, trachea, bronchus and lung, urinary tract and thyroid gland, drawn from the Norwegian Cause of Death Registry
Incidence of urinary tract cancer43 yearsDiagnosis of carcinoma in urinary tract, drawn from the Cancer Registry of Norway
Incidence of prostate cancer43 yearsDiagnosis of carcinoma in prostate, drawn from the Cancer Registry of Norway
Incidence of lung cancer43 yearsDiagnosis of carcinoma in lung, drawn from the Cancer Registry of Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026